Epidemiology and prevention of respiratory syncytial virus infections among infants and young children
- PMID: 21487331
- DOI: 10.1097/INF.0b013e3182184ae7
Epidemiology and prevention of respiratory syncytial virus infections among infants and young children
Abstract
Since its discovery in 1956, respiratory syncytial virus (RSV) has been recognized as one of the most common causes of serious lower respiratory tract infections in young children worldwide. While considered a high priority, development of a safe and effective vaccine has remained elusive. Prevention of RSV disease relies on infection control and hygiene measures, as well as providing immunoprophylaxis in select infants. The prophylaxis, however, is costly, and so targeting the recipient population and timing of administration is important for optimal effectiveness and judicious use of limited health care resources. This article reviews the epidemiology of RSV infections in infants and young children, including risk factors for severe disease, so as to inform decisions about prevention efforts.
Similar articles
-
Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease.Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S41-5. doi: 10.1097/01.inf.0000108220.94201.1a. Pediatr Infect Dis J. 2004. PMID: 14730269
-
Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.Adv Ther. 2011 Feb;28(2):110-25. doi: 10.1007/s12325-010-0101-y. Epub 2011 Feb 4. Adv Ther. 2011. PMID: 21318605 Review.
-
Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.Pediatrics. 2003 Dec;112(6 Pt 1):1442-6. Pediatrics. 2003. PMID: 14654627
-
Clinical and pharmacological aspects of immunoprophylaxis for respiratory syncytial virus infection in high-risk infants.Curr Drug Metab. 2013 Feb;14(2):216-25. Curr Drug Metab. 2013. PMID: 22935064 Review.
-
Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?Ir Med J. 2000 Dec;93(9):284. Ir Med J. 2000. PMID: 11209917
Cited by
-
Novel Approach for Detecting Respiratory Syncytial Virus in Pediatric Patients Using Machine Learning Models Based on Patient-Reported Symptoms: Model Development and Validation Study.JMIR Form Res. 2024 Apr 12;8:e52412. doi: 10.2196/52412. JMIR Form Res. 2024. PMID: 38608268 Free PMC article.
-
Prenatal Maternal Immunization for Infant Protection: A Review of the Vaccines Recommended, Infant Immunity and Future Research Directions.Pathogens. 2024 Feb 23;13(3):200. doi: 10.3390/pathogens13030200. Pathogens. 2024. PMID: 38535543 Free PMC article. Review.
-
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.MMWR Morb Mortal Wkly Rep. 2023 Oct 13;72(41):1115-1122. doi: 10.15585/mmwr.mm7241e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37824423 Free PMC article.
-
Diabetic Ketoacidosis in Northern Jordan: Seasonal Morbidity and Characteristics of Patients.Diabetes Metab Syndr Obes. 2023 Oct 3;16:3057-3064. doi: 10.2147/DMSO.S413405. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37810572 Free PMC article.
-
The road to approved vaccines for respiratory syncytial virus.NPJ Vaccines. 2023 Sep 25;8(1):138. doi: 10.1038/s41541-023-00734-7. NPJ Vaccines. 2023. PMID: 37749081 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
